Triangle Capital Corporation Announces Senior Management

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Triangle Capital Corporation Announces Senior Management Promotions

RALEIGH, N.C., Oct. 03, 2016 (GLOBE NEWSWIRE) -- Triangle Capital Corporation (NYSE: TCAP ) (“Triangle” or the “Company”), a leading provider of capital to lower middle market companies, announced today that its Board of Directors has approved the following senior management promotions:

  • Jeffrey A. Dombcik to Senior Managing Director and Chief Credit Officer;
  • Cary B. Nordan to Senior Managing Director and Chief Origination Officer; and  
  • Douglas A. Vaughn to Senior Managing Director and Chief Administrative Officer.

Messrs. Dombcik, Nordan and Vaughn will also join the Company’s Management Committee and become Executive Officers of the Company.

Commenting on the promotions, E. Ashton Poole, President and Chief Executive Officer, stated, “The promotions being announced today recognize three extremely talented individuals, all of whom are seasoned investment professionals with 29 years of collective service to Triangle. As Triangle continues to expand its presence and brand name across the lower middle market, their experience and leadership will provide the Company with increased bandwidth, functionality and accountability. Again, I am delighted to announce these well-deserved promotions.”

About Triangle Capital Corporation

Triangle Capital Corporation ( www.TCAP.com ) invests capital in established companies in the lower middle market to fund growth, changes of control and other corporate events.  Triangle offers a wide variety of investment structures with a primary focus on mezzanine financing with equity components.  Triangle’s investment objective is to seek attractive returns by generating current income from debt investments and capital appreciation from equity related investments.  Triangle’s investment philosophy is to partner with business owners, management teams and financial sponsors to provide flexible financing solutions.  Triangle typically invests $5.0 million - $35.0 million per transaction in companies with annual revenues between $20.0 million and $200.0 million and EBITDA between $3.0 million and $35.0 million.

Triangle has elected to be treated as a business development company under the Investment Company Act of 1940 ("1940 Act").  Triangle is required to comply with a series of regulatory requirements under the 1940 Act as well as applicable NYSE, federal and state laws and regulations.  Triangle has elected to be treated as a regulated investment company under the Internal Revenue Code of 1986. Failure to comply with any of the laws and regulations that apply to Triangle could have a material adverse effect on Triangle and its stockholders.

Forward Looking Statements

This press release may contain forward looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.  Any such statements, other than statements of historical fact, are likely to be affected by other unknowable future events and conditions, including elements of the future that are or are not under the Company's control, and that the Company may or may not have considered; accordingly, such statements cannot be guarantees or assurances of any aspect of future performance.  Actual developments and results are highly likely to vary materially from these estimates and projections of the future and some of these uncertainties are enumerated in Triangle’s filings with the Securities and Exchange Commission.  Certain factors that could cause actual results to differ materially from those contained in the forward-looking statements are included in our annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K, each as filed with the Securities and Exchange Commission. Copies are available on the SEC’s website at www.sec.gov and stockholders may receive a hard copy of the completed audited financial statements free of charge upon request to the Company at 3700 Glenwood Avenue, Suite 530, Raleigh, NC 27612. Such statements speak only as of the time when made, and the Company undertakes no obligation to update any such statement now or in the future.

Contacts Sheri Blair Colquitt Vice President, Investor Relations 919-719-4784 scolquitt@tcap.com Steven C. Lilly Chief Financial Officer 919-719-4789 slilly@tcap.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Gildan Faces Lawsuit: Allegations of Deceptive Practices Shake Investors

Updated Category News Views 192

Gildan's Troubles Unveiled The financial jungle can be a pretty treacherous place, and Gildan Activewear Inc. (NYSE: GIL) just found out how fickle the market can be. An 18.7% nosedive in Gildan's stock price after a securities fraud class action came knocking—if that isn't enough to stir up a hornet’s nest among investors, I don’t know what is. The Catalyst:...

Continue Reading
Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 134

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading
York Space Systems Class Action: Deadline Approaches

Updated Category News Views 104

Rapid Deadline: October 30 Looms for York Space Systems You blink, and you might miss the deadline. We’re just a step away from deadline day in the York Space Systems’ class action lawsuit. If you've got skin in this game, time's not on your side. Shareholders, particularly those who hopped on the York Space train via their IPO back in January 2026, are staring down...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 231

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
Joshua Davenport: Celebrating 25 Years in Healthcare

Updated Category News Views 113

25 Years Strong: Davenport's Journey in Healthcare Not every day you celebrate someone who's spent a quarter of a century in the trenches of healthcare. Joshua L. Davenport, RN, isn't just clocking years; he's built a legacy in emergency nursing and occupational health that speaks volumes about resilience and commitment to others. From Humble Beginnings to Health...

Continue Reading
Darden Faces Class Action Over Reimbursement Failures

Updated Category News Views 98

Class Action Puts Darden Restaurants in Legal Hot Seat Darden Restaurants, Inc. is staring down the barrel of a lawsuit that's as fiery as a grill on a Saturday night rush. The legal cavalry from Blumenthal Nordrehaug Bhowmik De Blouw LLP has stormed in with a class action complaint, aiming dead center at Darden for allegedly breaching the California Labor Code. In plain...

Continue Reading
Denarius Metals Unveils Technical Insight for Toral Project

Updated Category News Views 44

Denarius Metals Shares Tech Report on Toral Project It's a curious moment in the mining world when Denarius Metals decides to drop their latest gem—a technical report on the Toral Project. We're talking about a full-bodied document rooted in the stringent National Instrument 43-101 standards. This isn't some half-baked release; it's a robust assertion of where they...

Continue Reading
Duolingo Faces Class Action: Deadline Looms for Plaintiffs

Updated Category News Views 203

Shaking up the education sector like a hot potato, investors have been thrown for a loop with Duolingo’s latest legal debacle. News broke that Kahn Swick & Foti, LLC, with significant backing from their heavyweight partner and former Louisiana Attorney General Charles C. Foti Jr., is spearheading a class action lawsuit against Duolingo, Inc. (NasdaqGS: DUOL). It’s one...

Continue Reading
NEXT Properties Exchange Offers: The Full Breakdown

Updated Category News Views 163

What's the Deal with These Exchange Offers? You know, nothing says 'we're changing things up' like an exchange offer. So what did NEXT Properties do? Well, they laid down two offers for the books on their outstanding 6.950% and 6.390% senior notes, due in 2044 and 2050, respectively. These are getting swapped out for some fresh 7.731% senior sustainability-linked notes...

Continue Reading
DigitalXForce Booms with 514% Growth and Major Backing

Updated Category News Views 204

Massive Growth and Strategic Investment in DigitalXForce Now here’s a company that’s shaking things up—DigitalXForce. Right on the back of a staggering 514% growth, they’ve corralled a strategic investment from Arsenal Growth Equity. If you blink, you might miss just how fast they’re sprinting through the tech landscape. Institutional Support Backing the...

Continue Reading

Top 5 Most Recently Viewed Articles

Haven Tower Elevates Leaders for Strategic Expansion

Updated Category News Views 6

When a company starts moving its chess pieces around, savvy investors know it's time to pay attention. Haven Tower Group, a heavyweight in strategic communications for the wealth management realm, is shaking things up. They've promoted Mitch Manning to Chief Engagement Officer & Partner and brought on Grant Cox as Principal. These moves aren't just about office...

Continue Reading
CoStar Group Set to Release Q4 and Full Year 2024 Results

Updated Category News Views 205

CoStar Group Plans to Announce Financial Outcomes CoStar Group, Inc. (NASDAQ: CSGP), a prominent leader in online real estate marketplaces and analytics, is gearing up to present its financial results for the fourth quarter and the entirety of the 2024 fiscal year. The announcement will take place following the market's closing on a specified Tuesday, during which...

Continue Reading
Disc Medicine's Participation in Key Investor Conferences

Updated Category News Views 97

Disc Medicine to Participate in Key Investor Conferences Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company based in Watertown, Massachusetts, is setting the stage for crucial engagements with investors. The company focuses on the discovery, development, and commercialization of innovative treatments aimed at patients facing serious hematologic...

Continue Reading
Bollinger Motors Celebrates First B4 Truck Deliveries Ahead

Updated Category News Views 50

Bollinger Motors delivered its first B4 electric trucks to Nacarato Truck Centers back in September 2024, marking an important step in their operational journey. This deal was worth a solid $800,000—a number that certainly turned heads among desks tracking EV trends. The delivery set the stage for what traders hoped would be a stream of revenue as Bollinger established...

Continue Reading
Nasdaq Achieves Significant Growth and Future Predictions

Updated Category News Views 191

Revenue Highlights from Nasdaq's Latest Report Nasdaq, Inc. (NASDAQ:NDAQ) recently revealed impressive financial results, showcasing a remarkable revenue increase of 15% compared to the previous year, totaling $1.315 billion. This was a better outcome than analysts had anticipated, with expectations set at $1.297 billion. Strong Adjusted Earnings The financial services...

Continue Reading